Treatment of gastric marginal zone lymphoma of MALT type

Bibliography

• Neubauer A, Zucca E. Gastrointestinal tract lymphomas. In: Cavalli F, Stein H, Zucca E, editors, Extranodal lymphomas pathology and management. Informa Health Care, London; 2008. p. 233-43
   Google Scholar
• Ferrucci PF, Zucca E. Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years? Br J Haematol 2007;136:521-38
   PubMed Web of Science ®Google Scholar
• Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol 2005;23:6415-20
   PubMed Web of Science ®Google Scholar
• Thieblemont C, Coiffier B. MALT lymphoma: sites of presentations, clinical features and staging procedures. In: Zucca E, Bertoni F, editors, MALT lymphomas. Landes Bioscience/Kluwer Academic, Georgetown, TX, USA; 2004. p. 60-80
   Google Scholar
• Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-9
   PubMed Web of Science ®Google Scholar
• Du MQ, Isaacson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol 2002;3:97-104
   PubMed Web of Science ®Google Scholar
• Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer 2004;4:644-53
   PubMed Web of Science ®Google Scholar
• Bertoni F, Gascoyne RD. Pathobiology and molecular basis of MALT lymphoma. In: Cavalli F, Stein H, Zucca E, editors, Extranodal lymphomas pathology and management. Informa Health Care, London; 2008. p. 67-77
   Google Scholar
• Farinha P, Gascoyne RD. Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma. J Clin Oncol 2005;23:6370-8
   PubMed Web of Science ®Google Scholar
• Bertoni F, Zucca E. Delving deeper into MALT lymphoma biology. J Clin Invest 2006;116:22-6
   PubMed Web of Science ®Google Scholar
• Liu H, Ye H, Ruskone-Fourmestraux A, T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 2002;122:1286-94
   PubMed Web of Science ®Google Scholar
• Kuo SH, Chen LT, Yeh KH, Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol 2004;22:3491-7
   PubMed Web of Science ®Google Scholar
• Ye H, Gong L, Liu H, Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut 2006;55:137-8
   PubMed Web of Science ®Google Scholar
• Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut 2006;55:886-93
   PubMed Web of Science ®Google Scholar
• Tibiletti MG, Milani K, Martin V, Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type. Hematol Oncol 2007;25(4):184-8
   PubMedGoogle Scholar
• Streubel B, Lamprecht A, Dierlamm J, T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101(6):2335-9
   PubMed Web of Science ®Google Scholar
• Willis TG, Jadayel DM, Du MQ, Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 1999;96:35-45
   PubMed Web of Science ®Google Scholar
• Novak U, Rinaldi A, Kwee I, The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood 2009;113:4918-21
   PubMed Web of Science ®Google Scholar
• Stathis A, Chini C, Bertoni F, Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 2009;20:1086-93
   PubMed Web of Science ®Google Scholar
• Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 2007;56:1685-7
   PubMed Web of Science ®Google Scholar
• Wundisch T, Thiede C, Morgner A, Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 2005;23:8018-24
   PubMed Web of Science ®Google Scholar
• Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20(Suppl 4):113-4
   PubMed Web of Science ®Google Scholar
• Thiede C, Wundisch T, Alpen B, Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001;19:1600-9
   PubMed Web of Science ®Google Scholar
• Bertoni F, Conconi A, Capella C, Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002;99:2541-4
   PubMed Web of Science ®Google Scholar
• Isaacson PG, Chott A, Nakamura S, Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow S, Campo E, Harris NL, , editors, WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon; 2008. p. 214-7
   Google Scholar
• Chan JK. Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol 1996;13:260-96
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Wotherspoon A. MALT lymphoma pathology, initial diagnosis, and posttreatment evaluation. In: Cavalli F, Stein H, Zucca E, editors, Extranodal lymphomas pathology and management. Informa Health Care, London; 2008. p. 114-23
   Google Scholar
• Eck M, Schmausser B, Haas R, MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997;112:1482-6
   PubMed Web of Science ®Google Scholar
• Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005;16:473-80
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kletter K, Becherer A, 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 2003;64:336-40
   PubMed Web of Science ®Google Scholar
• Yi JH, Kim SJ, Choi JY, (18)F-FDG uptake and its clinical relevance in primary gastric lymphoma. Hematol Oncol 2010;28(2):57-61
   PubMedGoogle Scholar
• de Jong D, Aleman BM, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 1999;10:275-80
   PubMed Web of Science ®Google Scholar
• Rohatiner A, d'Amore F, Coiffier B, Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400
   PubMed Web of Science ®Google Scholar
• Sackmann M, Morgner A, Rudolph B, Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997;113:1087-90
   PubMed Web of Science ®Google Scholar
• Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment. Gut 2001;48:297-303
   PubMed Web of Science ®Google Scholar
• Steinbach G, Ford R, Glober G, Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999;131:88-95
   PubMed Web of Science ®Google Scholar
• Ruskone-Fourmestraux A, Dragosics B, Morgner A, Paris staging system for primary gastrointestinal lymphomas. Gut 2003;52:912-3
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Andriani A, Primary low-grade and high-grade gastric MALT-lymphoma presentation. J Clin Gastroenterol 2010;44:340-4
   PubMed Web of Science ®Google Scholar
• Zucca E, Pinotti G, Roggero E, High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol 1995;6:726-8
   PubMed Web of Science ®Google Scholar
• Pinotti G, Zucca E, Roggero E, Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997;26:527-37
   PubMed Web of Science ®Google Scholar
• Raderer M, Osterreicher C, Machold K, Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol 2001;12:937-9
   PubMed Web of Science ®Google Scholar
• Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983;52:1410-6
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6
   PubMed Web of Science ®Google Scholar
• Nakamura S, Yao T, Aoyagi K, Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997;79:3-11
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Hansen S, Rodriguez L, Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71
   PubMed Web of Science ®Google Scholar
• Doglioni C, Wotherspoon AC, Moschini A, High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992;339:834-5
   PubMed Web of Science ®Google Scholar
• Zucca E, Bertoni F, Roggero E, Molecular analysis of the progression from Helicobacter pylori- associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804-10
   PubMed Web of Science ®Google Scholar
• Nakamura S, Aoyagi K, Furuse M, B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 1998;152:1271-9
   PubMed Web of Science ®Google Scholar
• Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa- associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-4
   PubMed Web of Science ®Google Scholar
• Wotherspoon AC, Doglioni C, Diss TC, Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7
   PubMed Web of Science ®Google Scholar
• Roggero E, Zucca E, Pinotti G, Eradication of Helicobacter pylori infection in primary low- grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-9
   PubMed Web of Science ®Google Scholar
• Bayerdorffer E, Neubauer A, Rudolph B, Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591-4
   PubMed Web of Science ®Google Scholar
• Zucca E, Cavalli F. Are antibiotics the treatment of choice for gastric lymphoma? Curr Hematol Rep 2004;3:11-6
   PubMedGoogle Scholar
• Thieblemont C, Dumontet C, Bouafia F, Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001. Leuk Lymphoma 2003;44:257-62
   PubMed Web of Science ®Google Scholar
• Andriani A, Miedico A, Tedeschi L, Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis 2009;41:467-73
   PubMedGoogle Scholar
• Terai S, Iijima K, Kato K, Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 2008;214:79-87
   PubMedGoogle Scholar
• Kim JS, Chung SJ, Choi YS, Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer 2007;96:1324-8
   PubMedGoogle Scholar
• Montalban C, Santon A, Redondo C, Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 2005;16:1539-44
   PubMed Web of Science ®Google Scholar
• Fischbach W, Goebeler-Kolve ME, Dragosics B, Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34-7
   PubMed Web of Science ®Google Scholar
• de Jong D, Vyth-Dreese F, Dellemijn T, Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol 2001;193:318-24
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Cristofari F, Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 2010;8:105-10
   PubMed Web of Science ®Google Scholar
• Isaacson PG, Diss TC, Wotherspoon AC, Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibiotics. Gastroenterology 1999;117:750-1
   PubMed Web of Science ®Google Scholar
• Hancock B, Qian W, Linch D, Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol 2009;144(3):367-75
   PubMedGoogle Scholar
• Capelle LG, de Vries AC, Looman CW, Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 2008;44:2470-6
   PubMed Web of Science ®Google Scholar
• Chey WD, Wong BC. American college of gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25
   PubMed Web of Science ®Google Scholar
• Fuccio L, Laterza L, Zagari RM, Treatment of Helicobacter pylori infection. BMJ 2008;337:a1454
   PubMedGoogle Scholar
• Malfertheiner P, Megraud F, O'Morain C, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Andriani A, Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol 2009;104:1932-7; quiz 1938
   PubMedGoogle Scholar
• Neubauer A, Thiede C, Morgner A, Cure of Helicobacter pylori infection and duration of remission of low- grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-5
   PubMed Web of Science ®Google Scholar
• Copie-Bergman C, Gaulard P, Lavergne-Slove A, Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut 2003;52:1656
   PubMed Web of Science ®Google Scholar
• Nakamura S, Matsumoto T, Ye H, Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 2006;107:2770-8
   PubMedGoogle Scholar
• Raderer M, Streubel B, Wohrer S, Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut 2006;55:616-8
   PubMed Web of Science ®Google Scholar
• Martinelli G, Laszlo D, Ferreri AJ, Clinical activity of rituximab in gastric marginal zone non-hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005;23:1979-83
   PubMed Web of Science ®Google Scholar
• Conconi A, Martinelli G, Thieblemont C, Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-5
   PubMed Web of Science ®Google Scholar
• Zullo A, Hassan C, Andriani A, Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol 2010;27:291-5
   PubMed Web of Science ®Google Scholar
• Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998;16:1916-21
   PubMed Web of Science ®Google Scholar
• Schechter NR, Yahalom J. Low-grade MALT lymphoma of the stomach: a review of treatment options. Int J Radiat Oncol Biol Phys 2000;46:1093-103
   PubMed Web of Science ®Google Scholar
• Tsang RW, Gospodarowicz MK. Radiation therapy for localized low-grade non-Hodgkin's lymphomas. Hematol Oncol 2005;23:10-7
   PubMed Web of Science ®Google Scholar
• Tsang RW, Gospodarowicz MK, Pintilie M, Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003;21:4157-64
   PubMed Web of Science ®Google Scholar
• Park HC, Park W, Hahn JS, Low grade MALT lymphoma of the stomach: treatment outcome with radiotherapy alone. Yonsei Med J 2002;43:601-6
   PubMedGoogle Scholar
• Fung CY, Grossbard ML, Linggood RM, Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment. Cancer 1999;85:9-17
   PubMed Web of Science ®Google Scholar
• Gospodarowicz M, Tsang R. Radiation therapy of mucosa-associated lymphoid tissue (MALT) lymphomas. In: Zucca E, editor, MALT lymphomas. Landes Bioscience/Kluwer Academic, Georgetown, TX, USA; 2004. p. 104-29
   Google Scholar
• Hitchcock S, Ng AK, Fisher DC, Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2002;52:1058-66
   PubMed Web of Science ®Google Scholar
• Vrieling C, de Jong D, Boot H, Long-term results of stomach-conserving therapy in gastric MALT lymphoma. Radiother Oncol 2008;87:405-11
   PubMedGoogle Scholar
• Gobbi PG, Corbella F, Valentino F, Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy. Ann Oncol 2009;20:465-8
   PubMed Web of Science ®Google Scholar
• Yahalom J. MALT lymphomas: a radiation oncology viewpoint. Ann Hematol 2001;80(Suppl 3):B100-105
   PubMedGoogle Scholar
• Della Biancia C, Hunt M, Furhang E, Radiation treatment planning techniques for lymphoma of the stomach. Int J Radiat Oncol Biol Phys 2005;62:745-51
   PubMed Web of Science ®Google Scholar
• NCCN. National Comprehensive Cancer Network Guidelines V.3.2008–Non-Hodgkin's Lymphoma. In edition. Available from: http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf [Last accessed on 11 November 2008]
   Google Scholar
• Aleman BM, Haas RL, van der Maazen RW. Role of radiotherapy in the treatment of lymphomas of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2010;24:27-34
   PubMedGoogle Scholar
• Hammel P, Haioun C, Chaumette MT, Efficacy of single-agent chemotherapy in low-grade B-cell mucosa- associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995;13:2524-9
   PubMed Web of Science ®Google Scholar
• Levy M, Copie-Bergman C, Gameiro C, Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 2005;23:5061-6
   PubMed Web of Science ®Google Scholar
• Jager G, Neumeister P, Brezinschek R, Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002;20:3872-7
   PubMed Web of Science ®Google Scholar
• Salar A, Domingo-Domenech E, Estany C, Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Cancer 2009;115:5210-7
   PubMed Web of Science ®Google Scholar
• Brown JR, Friedberg JW, Feng Y, A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol 2009;145:741-8
   PubMed Web of Science ®Google Scholar
• Levy M, Copie-Bergman C, Molinier-Frenkel V, Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up. Leuk Lymphoma 2010;51:284-90
   PubMed Web of Science ®Google Scholar
• Zucca E, Conconi A, Martelli M, Interim analysis of the IELSG-19 randomised study of chlorambucil alone versus chlorambucil plus rituximab versus rituximab alone in extranodal marginal zone lymphomas of Mucosa-Associated Lymphoid Tissue (MALT lymphoma). ASH Annual Meeting Abstracts. Blood 2009;114:3939
   Google Scholar
• de Mascarel A, Ruskone-Fourmestraux A, Lavergne-Slove A, Clinical, histological and molecular follow-up of 60 patients with gastric marginal zone lymphoma of mucosa-associated lymphoid tissue. Virchows Arch 2005;446:219-24
   PubMed Web of Science ®Google Scholar
• Begum S, Sano T, Endo H, Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases. J Med Invest 2000;47:36-46
   PubMedGoogle Scholar
• Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19(Suppl 2):ii70-71
   PubMedGoogle Scholar
• Fischbach W, Goebeler-Kolve M, Starostik P, Minimal residual low-grade gastric MALT-type lymphoma after eradication of Helicobacter pylori. Lancet 2002;360:547-8
   PubMed Web of Science ®Google Scholar